Merz Therapeutics

Are you passionate about growth, innovation, strategy, and driving business success? Join our team as Head of Competitive & Strategic Insights!   At Merz Therapeutics, we're committed to growth: you'll play a critical role in the future success of our organization as we continually work toward #BetterOutcomesForMorePatients.   Learn more about this position: https://lnkd.in/dd6kwuK7

At Merz Therapeutics, we believe that partnerships are the cornerstone of innovation and growth. Collaborating with like-minded organizations allows us to combine strengths, share resources, and achieve greater success together. Find out how we can make a difference together: https://lnkd.in/egchjjFy 

If you care about your brain health, click through the post and incorporate these five tips into your daily routine. The brain is our most vital organ, controlling everything from our thoughts and emotions to our movements and senses. Keeping it healthy is critical to your overall well-being and quality of life. #BetterOutcomesForMorePatients #WorldBrainDay #WBD2024 #BrainHealthandPrevention

Collaboration and mutual respect are at the heart of our approach, enabling us to tackle complex challenges and develop breakthrough treatments. By fostering a team culture that values the contributions of each member, we continue to advance our mission of improving patients' quality of life. Become a part of our R&D team: https://lnkd.in/eMcuctE6 

Did you know that more than 15 million people worldwide are living with a #spinalcordinjury (SCI)? Rehabilitation is a challenging journey that requires resilience, dedication, and comprehensive care, but with the right support, individuals can achieve remarkable levels of independence and quality of life.

The innovative strength of our R&D team illustrates the power of collaboration and diversity to achieve breakthroughs in patient care. Together, we are committed to pushing the boundaries of medical science to deliver #BetterOutcomesForMorePatients.

For investors and media: We are excited to announce that Merz Therapeutics has officially closed on the acquisition of two commercial medicines, INBRIJA® and AMPYRA®, from Acorda Therapeutics. With these products officially a part of our growing portfolio, we will be able to offer additional treatment options for #Parkinsons related symptoms and, for the first time, #MultipleSclerosis (MS) walking difficulties. The addition of these assets underlines Merz Therapeutics’ global Pivot for Growth strategy to evolve both the current portfolio and achieve critical scale and global reach through acquisitions, while delivering on our ongoing commitment of bringing #BetterOutcomesForMorePatients. Merz Therapeutics is poised to continue building on what we have accomplished in the specialty neurology space by strengthening our market position in Parkinson’s disease and entering the MS segment. This deal demonstrates the organization’s interest and ability to acquire assets in neurology-focused specialty care, driven by the needs of people living with movement disorders and neurological conditions. Read more about the acquisition in our press release:  https://lnkd.in/g6yQHSNr #HealthcareInnovation #NeurologyCare Important Safety information: https://lnkd.in/gKbduB4q https://lnkd.in/gyZrZZdr European Medicines Agency (EMA): https://lnkd.in/ezxdVzSP https://lnkd.in/e7g2QT2d

Did you know that 75% to 80% of people living with #cerebralpalsy experience spasticity? This symptom can lead to a limited range of joint motion, reduced motor function, and pain. By addressing these challenges and showing our support, we can help individuals lead more independent and fulfilling lives. Let’s work together to build a more inclusive and supportive community. #BetterOutcomesForMorePatients

As we continue to push the boundaries of innovation in the pharmaceutical industry, the role of patient advocacy organizations in R&D has never been more important. Patient organizations bring invaluable perspectives that help shape clinical development programs, making them more effective and patient-centered. At #MerzTx, we're proud to put patients first: Their voices are not only heard, but they are also integral to our work, from the early stages of research to the final stages of development. Learn more about the patient organizations we work with: https://lnkd.in/dY48tpz7 

Ensuring continued safety of our products is vital to our mission: Better outcomes for more patients. Julia Pfaff, our Head of Pharmacovigilance, sheds light on the critical process of post-approval product monitoring. Explore our clinical breakthroughs: https://lnkd.in/eT_aduCR